Results 121 to 130 of about 1,210 (152)

Letter to Editor Regarding the OCEAN Study [Letter]. [PDF]

Int J Chron Obstruct Pulmon Dis, 2021
Yawn BP, Make B, Mannino D, Martinez FJ, Han MK.   +4 more
europepmc   +1 more source

Barriers and facilitators for implementing WHO's Surgical Safety Checklist in a publicly funded hospital: a qualitative study from a tertiary-level public hospital in Croatia. [PDF]

BMJ Open
Krstulović J, Ursić L, Hrgović Z, Šuljić N, Roje R, Znaor L, Marusic A.   +6 more
europepmc   +1 more source

Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison. [PDF]

Pulm Ther
Bhatt SP, Freemantle N, Soliman M, Heble J, Cabon Y, Mayen Herrera E, Yang J, Xu Y.   +7 more
europepmc   +1 more source

Substance use and menopausal symptoms among people with and without HIV in the US, 2008-2020. [PDF]

Menopause
Knittel AK, Knittel AK, Bullington BW, Edmonds A, Rahangdale L, Neal-Perry G, Ramirez C, Konkle-Parker D, Jones DL, Moran CA, Topper EF, Cejtin H, Seidman D, Kasseye SG, Wilson TE, Sharma A, Adimora AA.   +16 more
europepmc   +1 more source

Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. [PDF]

Hepatol Commun
Sanyal AJ, Loomba R, Anstee QM, Ratziu V, Kowdley KV, Rinella ME, Harrison SA, Resnick MB, Capozza T, Sawhney S, Shelat N, Younossi ZM.   +11 more
europepmc   +1 more source

Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population. [PDF]

Respir Med
Quezada WA, Angulo D, Murray S, Joo M, Han M, Make B, Thomashow B, Mannino D, Tapp H, Martinez F, Yawn BP.   +10 more
europepmc   +1 more source

Perspectives on benefits and risks of creation of an "injection drug use" billing code. [PDF]

J Subst Use Addict Treat
Sundaram G, Sato T, Goodman-Meza D, Haddad M, Thakarar K, Feinberg J, Springer SA, Barton K, Butler N, Eaton EF, Wurcel AG.   +10 more
europepmc   +1 more source

Defining disease stability in chronic obstructive pulmonary disease: evidence from phase 3 clinical trials. [PDF]

Am J Respir Crit Care Med
Singh D, Stacey R, Halpin DMG, Bhatt SP, Crawford J, Drury T, Di Boscio V, Kolterer S, Han MK.   +8 more
europepmc   +1 more source

Dupilumab in chronic obstructive pulmonary disease: a pooled analysis of emergency department visits, hospital admissions, and systemic corticosteroid use. [PDF]

Am J Respir Crit Care Med
Bhatt SP, Martinez FJ, Satia I, Anzueto A, Bourbeau J, Papi A, Korn S, Deslée G, Xia C, Heble J, Soliman M, Bafadhel M.   +11 more
europepmc   +1 more source